Ask AI

Two Drugs or Three? Navigating the Latest Evidence for Oral ART Initiation

For decades, 3-drug regimens (3DR) were considered the “gold standard” of antiretroviral therapy for HIV. However, numerous clinical trials and real-world studies demonstrated that modern 2-drug regimens (2DRs), both oral and long-acting injectable, are noninferior to 3DR alternatives. In this program, you’ll learn practical frameworks and evidence to help you make confident, individualized decisions between 2- and 3-drug regimens when initiating antiretroviral therapy.

Share

Program Content

Events

Activities

ART simplification
ART: Not One Drug Fewer Than Necessary, And Not One More
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 10, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported by an educational grant from ViiV Healthcare.

ViiV Healthcare